March 24, 2022
Via: Washington's Top NewsWhen patients are battling a terminal illness and want access to an experimental drug, how much evidence that it works should regulators require before approval? That’s the question behind many of the Food and Drug Administration’s toughest decisions, including last […]
December 11, 2023
December 11, 2023